Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cannabinoid-based Products for Cancer Market Growth (Status and Outlook) 2022-2028

  • LP 4889369
  • 87 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cannabinoid-based Products for Cancer will have significant change from previous year. According to our (LP Information) latest study, the global Cannabinoid-based Products for Cancer market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cannabinoid-based Products for Cancer market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cannabinoid-based Products for Cancer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cannabinoid-based Products for Cancer market, reaching US$ million by the year 2028. As for the Europe Cannabinoid-based Products for Cancer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cannabinoid-based Products for Cancer players cover Bausch Health, GW Pharmaceuticals, Cannabics Inc., and Tikun Olam, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cannabinoid-based Products for Cancer market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Smoking Products

Food Products

Oil

Coat Product

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Clinics

Hospitals

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Bausch Health

GW Pharmaceuticals

Cannabics Inc.

Tikun Olam

Jay Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cannabinoid-based Products for Cancer Market Size 2017-2028

2.1.2 Cannabinoid-based Products for Cancer Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cannabinoid-based Products for Cancer Segment by Type

2.2.1 Smoking Products

2.2.2 Food Products

2.2.3 Oil

2.2.4 Coat Product

2.2.5 Other

2.3 Cannabinoid-based Products for Cancer Market Size by Type

2.3.1 Cannabinoid-based Products for Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cannabinoid-based Products for Cancer Market Size Market Share by Type (2017-2022)

2.4 Cannabinoid-based Products for Cancer Segment by Application

2.4.1 Clinics

2.4.2 Hospitals

2.4.3 Others

2.5 Cannabinoid-based Products for Cancer Market Size by Application

2.5.1 Cannabinoid-based Products for Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cannabinoid-based Products for Cancer Market Size Market Share by Application (2017-2022)

3 Cannabinoid-based Products for Cancer Market Size by Player

3.1 Cannabinoid-based Products for Cancer Market Size Market Share by Players

3.1.1 Global Cannabinoid-based Products for Cancer Revenue by Players (2020-2022)

3.1.2 Global Cannabinoid-based Products for Cancer Revenue Market Share by Players (2020-2022)

3.2 Global Cannabinoid-based Products for Cancer Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cannabinoid-based Products for Cancer by Regions

4.1 Cannabinoid-based Products for Cancer Market Size by Regions (2017-2022)

4.2 Americas Cannabinoid-based Products for Cancer Market Size Growth (2017-2022)

4.3 APAC Cannabinoid-based Products for Cancer Market Size Growth (2017-2022)

4.4 Europe Cannabinoid-based Products for Cancer Market Size Growth (2017-2022)

4.5 Middle East & Africa Cannabinoid-based Products for Cancer Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cannabinoid-based Products for Cancer Market Size by Country (2017-2022)

5.2 Americas Cannabinoid-based Products for Cancer Market Size by Type (2017-2022)

5.3 Americas Cannabinoid-based Products for Cancer Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cannabinoid-based Products for Cancer Market Size by Region (2017-2022)

6.2 APAC Cannabinoid-based Products for Cancer Market Size by Type (2017-2022)

6.3 APAC Cannabinoid-based Products for Cancer Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cannabinoid-based Products for Cancer by Country (2017-2022)

7.2 Europe Cannabinoid-based Products for Cancer Market Size by Type (2017-2022)

7.3 Europe Cannabinoid-based Products for Cancer Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cannabinoid-based Products for Cancer by Region (2017-2022)

8.2 Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Type (2017-2022)

8.3 Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cannabinoid-based Products for Cancer Market Forecast

10.1 Global Cannabinoid-based Products for Cancer Forecast by Regions (2023-2028)

10.1.1 Global Cannabinoid-based Products for Cancer Forecast by Regions (2023-2028)

10.1.2 Americas Cannabinoid-based Products for Cancer Forecast

10.1.3 APAC Cannabinoid-based Products for Cancer Forecast

10.1.4 Europe Cannabinoid-based Products for Cancer Forecast

10.1.5 Middle East & Africa Cannabinoid-based Products for Cancer Forecast

10.2 Americas Cannabinoid-based Products for Cancer Forecast by Country (2023-2028)

10.2.1 United States Cannabinoid-based Products for Cancer Market Forecast

10.2.2 Canada Cannabinoid-based Products for Cancer Market Forecast

10.2.3 Mexico Cannabinoid-based Products for Cancer Market Forecast

10.2.4 Brazil Cannabinoid-based Products for Cancer Market Forecast

10.3 APAC Cannabinoid-based Products for Cancer Forecast by Region (2023-2028)

10.3.1 China Cannabinoid-based Products for Cancer Market Forecast

10.3.2 Japan Cannabinoid-based Products for Cancer Market Forecast

10.3.3 Korea Cannabinoid-based Products for Cancer Market Forecast

10.3.4 Southeast Asia Cannabinoid-based Products for Cancer Market Forecast

10.3.5 India Cannabinoid-based Products for Cancer Market Forecast

10.3.6 Australia Cannabinoid-based Products for Cancer Market Forecast

10.4 Europe Cannabinoid-based Products for Cancer Forecast by Country (2023-2028)

10.4.1 Germany Cannabinoid-based Products for Cancer Market Forecast

10.4.2 France Cannabinoid-based Products for Cancer Market Forecast

10.4.3 UK Cannabinoid-based Products for Cancer Market Forecast

10.4.4 Italy Cannabinoid-based Products for Cancer Market Forecast

10.4.5 Russia Cannabinoid-based Products for Cancer Market Forecast

10.5 Middle East & Africa Cannabinoid-based Products for Cancer Forecast by Region (2023-2028)

10.5.1 Egypt Cannabinoid-based Products for Cancer Market Forecast

10.5.2 South Africa Cannabinoid-based Products for Cancer Market Forecast

10.5.3 Israel Cannabinoid-based Products for Cancer Market Forecast

10.5.4 Turkey Cannabinoid-based Products for Cancer Market Forecast

10.5.5 GCC Countries Cannabinoid-based Products for Cancer Market Forecast

10.6 Global Cannabinoid-based Products for Cancer Forecast by Type (2023-2028)

10.7 Global Cannabinoid-based Products for Cancer Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bausch Health

11.1.1 Bausch Health Company Information

11.1.2 Bausch Health Cannabinoid-based Products for Cancer Product Offered

11.1.3 Bausch Health Cannabinoid-based Products for Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bausch Health Main Business Overview

11.1.5 Bausch Health Latest Developments

11.2 GW Pharmaceuticals

11.2.1 GW Pharmaceuticals Company Information

11.2.2 GW Pharmaceuticals Cannabinoid-based Products for Cancer Product Offered

11.2.3 GW Pharmaceuticals Cannabinoid-based Products for Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GW Pharmaceuticals Main Business Overview

11.2.5 GW Pharmaceuticals Latest Developments

11.3 Cannabics Inc.

11.3.1 Cannabics Inc. Company Information

11.3.2 Cannabics Inc. Cannabinoid-based Products for Cancer Product Offered

11.3.3 Cannabics Inc. Cannabinoid-based Products for Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Cannabics Inc. Main Business Overview

11.3.5 Cannabics Inc. Latest Developments

11.4 Tikun Olam

11.4.1 Tikun Olam Company Information

11.4.2 Tikun Olam Cannabinoid-based Products for Cancer Product Offered

11.4.3 Tikun Olam Cannabinoid-based Products for Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Tikun Olam Main Business Overview

11.4.5 Tikun Olam Latest Developments

11.5 Jay Pharma

11.5.1 Jay Pharma Company Information

11.5.2 Jay Pharma Cannabinoid-based Products for Cancer Product Offered

11.5.3 Jay Pharma Cannabinoid-based Products for Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Jay Pharma Main Business Overview

11.5.5 Jay Pharma Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Cannabinoid-based Products for Cancer Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Smoking Products

Table 3. Major Players of Food Products

Table 4. Major Players of Oil

Table 5. Major Players of Coat Product

Table 6. Major Players of Other

Table 7. Cannabinoid-based Products for Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Cannabinoid-based Products for Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Cannabinoid-based Products for Cancer Market Size Market Share by Type (2017-2022)

Table 10. Cannabinoid-based Products for Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Cannabinoid-based Products for Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Cannabinoid-based Products for Cancer Market Size Market Share by Application (2017-2022)

Table 13. Global Cannabinoid-based Products for Cancer Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Cannabinoid-based Products for Cancer Revenue Market Share by Player (2020-2022)

Table 15. Cannabinoid-based Products for Cancer Key Players Head office and Products Offered

Table 16. Cannabinoid-based Products for Cancer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Cannabinoid-based Products for Cancer Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Cannabinoid-based Products for Cancer Market Size Market Share by Regions (2017-2022)

Table 21. Americas Cannabinoid-based Products for Cancer Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Cannabinoid-based Products for Cancer Market Size Market Share by Country (2017-2022)

Table 23. Americas Cannabinoid-based Products for Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Cannabinoid-based Products for Cancer Market Size Market Share by Type (2017-2022)

Table 25. Americas Cannabinoid-based Products for Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Cannabinoid-based Products for Cancer Market Size Market Share by Application (2017-2022)

Table 27. APAC Cannabinoid-based Products for Cancer Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Cannabinoid-based Products for Cancer Market Size Market Share by Region (2017-2022)

Table 29. APAC Cannabinoid-based Products for Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Cannabinoid-based Products for Cancer Market Size Market Share by Type (2017-2022)

Table 31. APAC Cannabinoid-based Products for Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Cannabinoid-based Products for Cancer Market Size Market Share by Application (2017-2022)

Table 33. Europe Cannabinoid-based Products for Cancer Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Cannabinoid-based Products for Cancer Market Size Market Share by Country (2017-2022)

Table 35. Europe Cannabinoid-based Products for Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Cannabinoid-based Products for Cancer Market Size Market Share by Type (2017-2022)

Table 37. Europe Cannabinoid-based Products for Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Cannabinoid-based Products for Cancer Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Cannabinoid-based Products for Cancer

Table 46. Key Market Challenges & Risks of Cannabinoid-based Products for Cancer

Table 47. Key Industry Trends of Cannabinoid-based Products for Cancer

Table 48. Global Cannabinoid-based Products for Cancer Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Cannabinoid-based Products for Cancer Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Cannabinoid-based Products for Cancer Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Cannabinoid-based Products for Cancer Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Cannabinoid-based Products for Cancer Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Cannabinoid-based Products for Cancer Market Size Market Share Forecast by Application (2023-2028)

Table 54. Bausch Health Details, Company Type, Cannabinoid-based Products for Cancer Area Served and Its Competitors

Table 55. Bausch Health Cannabinoid-based Products for Cancer Product Offered

Table 56. Bausch Health Cannabinoid-based Products for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Bausch Health Main Business

Table 58. Bausch Health Latest Developments

Table 59. GW Pharmaceuticals Details, Company Type, Cannabinoid-based Products for Cancer Area Served and Its Competitors

Table 60. GW Pharmaceuticals Cannabinoid-based Products for Cancer Product Offered

Table 61. GW Pharmaceuticals Main Business

Table 62. GW Pharmaceuticals Cannabinoid-based Products for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. GW Pharmaceuticals Latest Developments

Table 64. Cannabics Inc. Details, Company Type, Cannabinoid-based Products for Cancer Area Served and Its Competitors

Table 65. Cannabics Inc. Cannabinoid-based Products for Cancer Product Offered

Table 66. Cannabics Inc. Main Business

Table 67. Cannabics Inc. Cannabinoid-based Products for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Cannabics Inc. Latest Developments

Table 69. Tikun Olam Details, Company Type, Cannabinoid-based Products for Cancer Area Served and Its Competitors

Table 70. Tikun Olam Cannabinoid-based Products for Cancer Product Offered

Table 71. Tikun Olam Main Business

Table 72. Tikun Olam Cannabinoid-based Products for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Tikun Olam Latest Developments

Table 74. Jay Pharma Details, Company Type, Cannabinoid-based Products for Cancer Area Served and Its Competitors

Table 75. Jay Pharma Cannabinoid-based Products for Cancer Product Offered

Table 76. Jay Pharma Main Business

Table 77. Jay Pharma Cannabinoid-based Products for Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Jay Pharma Latest Developments

List of Figures

Figure 1. Cannabinoid-based Products for Cancer Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cannabinoid-based Products for Cancer Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cannabinoid-based Products for Cancer Market Size Market Share by Type in 2021

Figure 7. Cannabinoid-based Products for Cancer in Clinics

Figure 8. Global Cannabinoid-based Products for Cancer Market: Clinics (2017-2022) & ($ Millions)

Figure 9. Cannabinoid-based Products for Cancer in Hospitals

Figure 10. Global Cannabinoid-based Products for Cancer Market: Hospitals (2017-2022) & ($ Millions)

Figure 11. Cannabinoid-based Products for Cancer in Others

Figure 12. Global Cannabinoid-based Products for Cancer Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Cannabinoid-based Products for Cancer Market Size Market Share by Application in 2021

Figure 14. Global Cannabinoid-based Products for Cancer Revenue Market Share by Player in 2021

Figure 15. Global Cannabinoid-based Products for Cancer Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Cannabinoid-based Products for Cancer Market Size 2017-2022 ($ Millions)

Figure 17. APAC Cannabinoid-based Products for Cancer Market Size 2017-2022 ($ Millions)

Figure 18. Europe Cannabinoid-based Products for Cancer Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Cannabinoid-based Products for Cancer Market Size 2017-2022 ($ Millions)

Figure 20. Americas Cannabinoid-based Products for Cancer Value Market Share by Country in 2021

Figure 21. Americas Cannabinoid-based Products for Cancer Consumption Market Share by Type in 2021

Figure 22. Americas Cannabinoid-based Products for Cancer Market Size Market Share by Application in 2021

Figure 23. United States Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Cannabinoid-based Products for Cancer Market Size Market Share by Region in 2021

Figure 28. APAC Cannabinoid-based Products for Cancer Market Size Market Share by Application in 2021

Figure 29. China Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Cannabinoid-based Products for Cancer Market Size Market Share by Country in 2021

Figure 36. Europe Cannabinoid-based Products for Cancer Market Size Market Share by Type in 2021

Figure 37. Europe Cannabinoid-based Products for Cancer Market Size Market Share by Application in 2021

Figure 38. Germany Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Market Share by Application in 2021

Figure 46. Egypt Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Cannabinoid-based Products for Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 52. APAC Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 53. Europe Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 55. United States Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 56. Canada Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 59. China Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 60. Japan Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 61. Korea Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 63. India Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 64. Australia Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 65. Germany Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 66. France Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 67. UK Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 68. Italy Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 69. Russia Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 70. Spain Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 73. Israel Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Cannabinoid-based Products for Cancer Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450